Rare and unusual antibiotic resistance can be stamped out with aggressive prevention and control strategies.
The relatively new field of improvement science provides a framework for research focused on health care improvement.
Clarithromycin may lead to an increased chance of heart problems or death years after use.
Extra inpatient costs may top $4,000, though confirmatory testing doesn’t confirm most reported allergies.
Stewardship, monitoring, education, and thoughtful de-escalation can help avoid the overuse of sepsis drugs.
Ceftazidime/avibactam is the first new option in years for treatment of HABP/VABP caused by Gram-negative bacteria.
It’s important for physicians to know the policies that are aligned with, and those that may undermine, what they’re doing to improve their...
Several factors were predictive of mortality risk in hospitalized patients with multidrug resistant Gram-negative infections.
A brief roundup of HM-centric research.
While antibiotic stewardship is an issue relevant to nearly all hospitalists, for pediatric patients the considerations can be unique.